Adrenocortical cancer specialist centres NSW
Actions for Health Professionals
Patient referral
Patients with a suspected or confirmed adrenocortical cancer should be referred to a specialist who is a member of a multidisciplinary cancer care team, and practices at one of the specialist centres listed below.
Even if surgery does not seem likely at the time of referral, involvement of an appropriate a multidisciplinary team (MDT) early in the cancer journey is recommended to ensure optimal assessment, care, and outcomes.
The Canrefer website allows you to find cancer specialists who are MDT members, and has information about cancer services, optimal care pathways, and patient resources.
Smoking cessation support
Evidence suggests that tobacco cessation following cancer diagnosis improves survival. It also reduces treatment-related complications (6, 7). Health professionals should discuss tobacco use with all patients and provide appropriate cessation support.
List of public specialist centres for adrenocortical cancer surgery
| Local health district | Hospital | Multidisciplinary care team |
|---|---|---|
Northern Sydney | Royal North Shore | |
Western Sydney | Liverpool | |
| Hunter New England | John Hunter | John Hunter Endocrine Surgery MDT |
List of private specialist centres for adrenocortical cancer surgery
| Local health district | Hospital | Multidisciplinary care team |
|---|---|---|
South Eastern Sydney | St George Private Hospital |
References
- Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A, De Krijger RR, et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. European journal of endocrinology. 2018;179(4):G1-G46.
- Glover AR, Ip JC, Zhao JT, Soon PS, Robinson BG, Sidhu SB. Current management options for recurrent adrenocortical carcinoma. OncoTargets and therapy. 2013;6:635.
- Wängberg B, Khorram-Manesh A, Jansson S, Nilsson B, Nilsson O, Jakobsson C, et al. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Endocrine-related cancer. 2010;17(1):265.
- Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P, Group AIRS. The Italian registry for adrenal cortical carcinoma: analysis of a multiinstitutional series of 129 patients. Surgery. 1996;119(2):161-70.
- Gratian L, Pura J, Dinan M, Reed S, Scheri R, Roman S, et al. Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Annals of surgical oncology. 2014;21(11):3509-14.
- Hounsome L, Verne J, Persad R, Bahl A, Gillatt D, Oxley J, et al. An audit of urological MDT decision making in the South West of England. Journal of Clinical Urology. 2018;11(4):254-7.
- Warren GW, Sobus S, Gritz ER. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. The Lancet Oncology. 2014;15(12):e568-e80.
